Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy improves survival of gastric cancer with peritoneal carcinomatosis: Evidence from an experimental study

Journal of Translational Medicine

Volumn 9, Issue , 2011, Pages

  Tang, Li ^a   Mei, Lie Jun ^a   Yang, Xiao Jun ^a   Huang, Chao Qun ^a   Zhou, Yun Feng ^a   Yonemura, Yutaka ^b   Li, Yan ^a  

^a ZHONGNAN HOSPITAL OF WUHAN UNIVERSITY   (China)

^b NPO Organization to Support Peritoneal Dissemination Treatment   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; CALCIUM ION; CARBOPLATIN; CHLORIDE ION; CREATININE; DOCETAXEL; HEMOGLOBIN; POTASSIUM ION; PROTEIN; SERUM GLOBULIN; SODIUM ION; UREA; ANTINEOPLASTIC AGENT;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALBUMIN BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ANESTHESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CALCIUM BLOOD LEVEL; CANCER CELL; CANCER CHEMOTHERAPY; CANCER MODEL; CHLORIDE BLOOD LEVEL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CYTOREDUCTIVE SURGERY; DIARRHEA; DRUG EFFICACY; DRUG SAFETY; ERYTHROCYTE COUNT; EXPERIMENTAL RABBIT; HEMOGLOBIN BLOOD LEVEL; HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY; HYPERTHERMIC THERAPY; KIDNEY FUNCTION TEST; LEUKOCYTE COUNT; LIVER FUNCTION TEST; MALE; MORTALITY; NEUTROPHIL COUNT; NONHUMAN; OVERALL SURVIVAL; PATHOLOGY; PERITONEAL CARCINOMATOSIS; PERITONEUM CANCER; POSTOPERATIVE HEMORRHAGE; POTASSIUM BLOOD LEVEL; PROTEIN BLOOD LEVEL; SODIUM BLOOD LEVEL; STOMACH CANCER; SUBMUCOSA; THROMBOCYTE COUNT; UREA NITROGEN BLOOD LEVEL; WEIGHT CHANGE; ANIMAL; METASTASIS; MULTIMODALITY CANCER THERAPY; PERITONEUM TUMOR; RABBIT; STOMACH TUMOR; SURVIVAL;

ANIMALS; ANTINEOPLASTIC AGENTS; COMBINED MODALITY THERAPY; HYPERTHERMIA, INDUCED; MALE; PERITONEAL NEOPLASMS; RABBITS; STOMACH NEOPLASMS; SURVIVAL ANALYSIS;

EID: 79955672181     PISSN: None     EISSN: 14795876     Source Type: Journal    
DOI: 10.1186/1479-5876-9-53     Document Type: Article

References (39)

1. Blair SL, Chu DZ, Schwarz RE. Outcome of palliative operations for malignant bowel obstruction in patients with peritoneal carcinomatosis from nongynecological cancer. Ann Surg Oncol 2001, 8:632-637. 10.1007/s10434-001-0632-1, 11569777.
2. Al-Shammaa HAH, Li Y, Yonemura Y. Current status and future strategies of cytoreductive surgery plus intraperitoneal hyperthemic for peritoneal carcinomatosis. World J Gastroenterol 2008, 14:1159-1166. 10.3748/wjg.14.1159, 2690662, 18300340.
3. Fizazi K, Doubre H, Le Chevalier T, Riviere A, Viala J, Daniel C, Robert L, Barthélemy P, Fandi A, Ruffié P. Combination of raltitrexed and oxaliplatin is an active regimen in malignant mesothelioma: Results of a phase II study. J Clin Oncol 2003, 21:349-354. 10.1200/JCO.2003.05.123, 12525529.
4. Gómez Portilla A, Cendoya I, López de Tejada I, Olabarria I, Martínez de Lecea C, Magrach L, Gil A, Echebarría J, Valdovinos M, Larrabide I. Peritoneal carcinomatosis of colorectal origin. Current treatment. Review and update. Rev Esp Enferm Dig 2005, 97:716-737.
5. Yonemura Y, Bando E, Kawamura T, Ito H, Endo Y, Miura M, Kiyosaki K, Sasaki T. Cytoreduction and intraperitoneal chemotherapy for carcinomatosis from gastric cancer. Cancer Treat Res 2007, 134:357-373.
6. Sadeghi B, Arvieux C, Glehen O, Beaujard AC, Rivoire M, Baulieux J, Fontaumard E, Brachet A, Caillot JL, Faure JL, Porcheron J, Peix JL, Francois Y, Vignal J, Gilly FN. Peritoneal carcinomatosis from non-gynecologic malignancies: results of the EVOCAPE 1 multicentric prospective study. Cancer 2000, 88:358-363. 10.1002/(SICI)1097-0142(20000115)88:2<358::AID-CNCR16>3.0.CO;2-O, 10640968.
7. Yang XJ, Li Y, al-shammaa HAH, Yang GL, Liu SP, Lu YL, Zhang JW, Yonemura Y. Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy improves survival in selected patients with peritoneal carcinomatosis from abdominal and pelvic malignancies: results of 21 cases. Ann Surg Oncol 2009, 16:345-351. 10.1245/s10434-008-0226-2, 19018599.
8. Yonemura Y, Kawamura T, Bandou E, Takahashi S, Sawa T, Matsuki. Treatment of peritoneal dissemination from gastric cancer by peritonectomy and chemohyperthermic peritoneal perfusion. Br J Surg 2005, 92:370-375. 10.1002/bjs.4695, 15739249.
9. Glehen O, Schreiber V, Cotte E, Sayag-Beaujard AC, Osinsky D, Freyer G, Francois Y, Vignal J, Gilly FN. Cytoreductive surgery and intraperitoneal chemohyperthermia for peritoneal carcinomatosis arising from gastric cancer. Arch Surg 2004, 139:20-26. 10.1001/archsurg.139.1.20, 14718269.
10. Mori T, Fujiwara Y, Sugita Y, Azama T, Ishii T, Taniguchi K, Yamazaki K, Takiguchi S, Yasuda T, Yano M, Monden M. Application of molecular diagnosis for detection of peritoneal micrometastasis and evaluation of preoperative chemotherapy in advanced gastric carcinoma. Ann Surg Oncol 2004, 11:14-20. 10.1007/BF02524340, 14699028.
11. Flatmark K, Reed W, Halvorsen T, Sørensen O, Wiig JN, Larsen SG, Fodstad T, Giercksky KE. Pseudomyxoma peritonei--two novel orthotopic mouse models portray the PMCA-I histopathologic subtype. BMC Cancer 2007, 7:116. 10.1186/1471-2407-7-116, 1920528, 17603904.
12. Braumann C, Jacobi CA, Rogalla S, Menenakos C, Fuehrer K, Trefzer U, Hofmann M. The tumor suppressive reagent taurolidine inhibits growth of malignant melanoma - a mouse model. J Surg Res 2007, 143:327-378.
13. Pelz JOW, Doerfer J, Decker M, Dimmler A, Hohenberger W, Meyer T. Hyperthermic intraperitoneal chemoperfusion (HIPEC) decrease wound strength of colonic anastomosis in a rat model. Int J Colorectal Dis 2007, 22:941-947. 10.1007/s00384-006-0246-y, 17245567.
14. Otto J, Jansen PL, Lucas S, Schumpelick V, Jansen M. Reduction of peritoneal carcinomatosis by intraperitoneal administration of phospholipids in rats. BMC Cancer 2007, 7:104. 10.1186/1471-2407-7-104, 1913062, 17584925.
15. Pelz JOW, Doerfer J, Dimmler A, Hohenberger W, Meyer T. Histological response of peritoneal carcinomatosis after hyperthermic intraperitoneal chemoperfusion (HIPEC) in experimental investigations. BMC Cancer 2006, 6:162. 10.1186/1471-2407-6-162, 1552087, 16792796.
16. Pelz JOW, Doerfer J, Hohenberger W, Meyer T. A new survival model for hyperthermic intraperitoneal chemotherapy (HIPEC) in tumor-bearing rats in the treatment of peritoneal carcinomatosis. BMC Cancer 2005, 5:56. 10.1186/1471-2407-5-56, 1174866, 15924622.
17. Braumann C, Stuhldreier B, Bobrich E, Menenakos C, Rogalla S, Jacobi CA. High doses of taurolidine inhibit advanced intraperitoneal tumor growth in rats. J Surg Res 2005, 129:129-135. 10.1016/j.jss.2005.03.012, 15916768.
18. Monneuse O, Mestrallet JP, Quash G, Gilly FN, Glehen O. Intraperitoneal treatment with dimethylthioampal DIMATE combined with surgical debulking is effective for experimental peritoneal carcinomatosis in a rat model. J Gastrointest Surg 2005, 9:769-774. 10.1016/j.gassur.2005.02.006, 15985231.
19. Mei LJ, Yang XJ, Tang L, al-shammaa HAH, Yonemura Y, Li Y. Establishment and identification of a rabbit model of peritoneal carcinomatosis from gastric cancer. BMC Cancer 2010, 10:124. 10.1186/1471-2407-10-124, 2858745, 20359350.
20. Yang XJ, Li Y, Yonemura Y. Cytoreductive surgery plus hyperthemic intraperitoneal chemotherapy to treat gastric cancer with ascites and/or peritoneal carcinomatosis: results from a Chinese center. J Surg Oncol 2010, 101:457-464. 10.1002/jso.21519, 20401915.
21. Stewart JH, Shen P, Levine EA. Intraperitoneal hyperthermic chemotherapy for peritoneal surface malignancy: Current status and future directions. Ann Surg Oncol 2005, 12:765-777. 10.1245/ASO.2005.12.001, 16132375.
22. Verwaal VJ, van Ruth S, de Bree E, van Slooten GW, van Tinteren H, Boot H, Zoetmulder FAN. Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer. J Clin OncoL 2003, 21:3737-3743. 10.1200/JCO.2003.04.187, 14551293.
23. Khatri VP. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal cancer: a panacea or just an obstacle course for the patient?. J Clin Oncol 2010, 28:5-7. 10.1200/JCO.2009.24.8500, 19917856.
24. Elias D, Delperro JR, Sideris L, Benhamou E, Pocard M, Baton O, Giovannini M, Lasser P. Treatment of peritoneal carcinomatosis from colorectal cancer: impact of complete cytoreductive surgery and difficulties in conducting randomized trials. Ann Surg Oncol 2004, 11:518-521. 10.1245/ASO.2004.09.008, 15123461.
25. Jansen M, Treutner KH, Jansen PL, Zuber S, Otto J, Tietze L, Schumpelick V. Inhibition of gastric cancer cell adhesion in nude mice by inraperitoneal phospholipids. World J Surg 2005, 29:708-714. 10.1007/s00268-005-7583-9, 15895297.
26. Buchhorn HM, Seidl C, Beck R, Saur D, Apostolidis C, Morgenstern A, Schwaiger M, Senekowitsch-Schmidtke R. Non-invasive visualisation of the development of peritoneal carcinomatosis and tumour regression after 213Bi-radioimmunotherapy using bioluminescence imaging. Eur J Nucl Med Mol Imaging 2007, 34:841-849. 10.1007/s00259-006-0311-3, 17206415.
27. Piso P, Aselmann H, von Wasielewski R, Dahlke MH, Klempnauer J, Schlitt HJ. Prevention of peritoneal carcinomatosis from human gastric cancer cells by adjuvant-type intraperitoneal immunotherapy in a SCID mouse model. Eur Surg Res 2003, 35:470-476. 10.1159/000073385, 14593230.
28. McCarty MF, Takeda A, Stoeltzing O, Liu W, Fan F, Reinmuth N, Akagi M, Bucana C, Mansfield PF, Ryan A, Ellis LM. ZD6126 inhibits orthotopic growth and peritoneal carcinomatosis in a mouse model of human gastric cancer. Br J Cancer 2004, 90:705-711. 10.1038/sj.bjc.6601490, 2410155, 14760388.
29. Kulu Y, Dorfman JD, Kuruppu D, Fuchs BC, Goodwin JM, Fujii T, Kuroda T, Lanuti M, Tanabe KK. Comparison of intravenous versus intraperitoneal administration of oncolytic herpes simplex virus 1 for peritoneal carcinomatosis in mice. Cancer Gene Ther 2009, 16:291-297. 10.1038/cgt.2008.83, 2657185, 18989355.
30. Hribaschek A, Kuhn R, Pross M, Meyer F, Fahlke J, Ridwelski K, Boltze C, Lippert H. Intraperitoneal versus intravenous CPT-11 given intra- and postoperatively for peritoneal carcinomatosis in a rat model. Surg Today 2006, 36:57-62.
31. Aarts F, Koppe MJ, Hendriks T, vanEerd JEM, Oyen WJG, Boerman OC, Bleichrodt RP. Timing of Adjuvant Radioimmunotherapy after Cytoreductive Surgery in Experimental Peritoneal Carcinomatosis of Colorectal Origin. Ann Surg Oncol 2006, 14:533-540.
32. Aarts F, Bleichrodt RP, de Man B, Lomme R, Boerman OC, Hendriks T. The effects of adjuvant experimental radioimmunotherapy and hyperthermic intraperitoneal chemotherapy on intestinal and abdominal healing after cytoreductive surgery for peritoneal carcinomatosis in the rat. Ann Surg Oncol 2008, 15:3299-3307. 10.1245/s10434-008-0070-4, 18712445.
33. Klaver YLB, Hendriks T, Lomme RMLM, Rutten HJT, Bleichrodt RP, de Hingh IHJT. Introperative hyperthemic intraperitoneal chemotherapy after cytoreductive surgery for pertitoneal carcinomatosis in an experimental model. Br J Surg 2010, 97:1874-1880. 10.1002/bjs.7249, 20806291.
34. Hartmann J, Kilian M, Atanassov V, Braumann C, Ordemann J, Jacobi CA. First surgical tumour reduction of peritoneal surface malignancy in a rat's model. Clin Exp Metastasis 2008, 25:445-449. 10.1007/s10585-008-9150-x, 18301991.
35. Raue W, Kilian M, Braumann C, Atanassow V, Makareinis A, Caldenas S, Schwenk W, Hartmann J. Multmodel approach for treatment of peritoneal surface malignancises in a tumer-bearing rat model. Int J Colorectol Dis 2010, 25:245-250.
36. Mavanur AA, Parimi V, Malley MO, Nikiforova M, Bartlett DL, Davison JM. Establishment and characterization of a murine xenograft model of appendiceal mucinous adenocarcinoma. Int J Exp Path 2010, 91:357-367.
37. Wei BR, Hoover SB, Ross MM, Zhou WD, Meani F, Edwards JB, Spehalski EI, Risinger JI, Alvord WG, Quiñones OA, Belluco C, Martella L, Campagnutta E, Ravaggi A, Dai RM, Goldsmith PK, Woolard KD, Pecorelli S, Liotta LA, Petricoin EF, Simpson RM. Serum S100A6 concentration predicts peritoneal tumor burden in mice with epithelial ovarian cancer and is associated with advanced stage in patients. PLoS ONE 2009, 4:e7670. 10.1371/journal.pone.0007670, 2765613, 19888321.
38. Sheth RA, Upadhyay R, Stangenberg L, Sheth R, Weissleder R, Mahmood U. Improved detection of ovarian cancer metastases by intraoperative quantitative fluorescence protease imaging in a pre-clinical modal. Gyn Oncol 2009, 112:616-22.
39. Greenaway J, Moorehead R, Shaw P, Petrik J. Epithelial-stromal interaction increases cell proliferation, survival and tumorigenicity in a mouse model of human epithelial ovarian cancer. Gyn Oncol 2008, 108:385-394.